EverQuote (EVER)
(Delayed Data from NSDQ)
$20.04 USD
+0.39 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.07 +0.03 (0.15%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.04 USD
+0.39 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.07 +0.03 (0.15%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
Zacks News
Here's Why Investors Should Retain Voya Financial Stock Now
by Zacks Equity Research
Voya Financial (VOYA) is poised to benefit from constant efforts to enhance products suite and reduce costs.
Prudential (PRU) Unit Inks Strategic Deal With PlanSource
by Zacks Equity Research
Prudential (PRU) expands partnership with PlanSource to optimize benefits shopping and enrollment experience.
Assurant (AIZ) Continues to Gain From Segmental Performance
by Zacks Equity Research
Assurant (AIZ) is poised to benefit from improved premium across its segments and prudent capital deployment.
eHealth Gains 19% YTD: Can the Stock Retain the Momentum?
by Zacks Equity Research
Solid performance of the Medicare business helps eHealth (EHTH) continues the bull run.
Radian Offers 6.625% $525 Million Senior Unsecured Notes
by Zacks Equity Research
Radian (RDN) displays prudence by issuing senior notes amid a low interest rate environment to procure funds.
Brown & Brown (BRO) Rides on Organic Growth, Expenses Rise
by Zacks Equity Research
Brown & Brown (BRO) is well poised for growth on the back of strategic mergers and acquisitions and robust capital position slightly offset by higher expenses.
Assurant Sells Investment in Ike, Focuses on Lifestyle
by Zacks Equity Research
Assurant (AIZ) sells interest in Ike Asistencia to focus on core lifestyle offerings in Latin America.
EverQuote, Inc. (EVER) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
EverQuote, Inc. (EVER) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EverQuote, Inc. (EVER) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote, Inc. (EVER) delivered earnings and revenue surprises of 16.67% and 5.42%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
EverQuote, Inc. (EVER) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
EverQuote, Inc. (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Hold Hartford Financial in Your Portfolio?
by Zacks Equity Research
Riding on its rising investment income, strategic initiatives and capital position, Hartford Financial (HIG) holds promise to reap benefits for investors.
Radian Group Steps Up Safety Measures Amid Coronavirus Outbreak
by Zacks Equity Research
Radian Group (RDN) takes precautionary steps against the novel coronavirus pandemic to ensure safety of its employees and customers.
EverQuote (EVER) Q4 Loss Narrower Than Expected, Revenues Beat
by Zacks Equity Research
EverQuote's (EVER) Q4 results reflect strong growth in consumer quote request volume and impressive performance across its insurance verticals.
EverQuote, Inc. (EVER) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote, Inc. (EVER) delivered earnings and revenue surprises of 33.33% and 8.16%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for EverQuote's (EVER) Q4 Earnings?
by Zacks Equity Research
EverQuote's (EVER) Q4 results are likely to reflect revenue growth and expansion in EBITDA.
Expand Your Portfolio with this First Profit Stock Screener
by Benjamin Rains
We are in the midst of the fourth quarter earnings season. This makes it a great time to use our 'First Profit' stock screener. The idea is to search for companies that recently reported their first quarterly profit...
Is EverQuote (EVER) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EVER) Outperforming Other Finance Stocks This Year?
Sea Limited (SE) Looks Good: Stock Adds 7.4% in Session
by Zacks Equity Research
Sea Limited (SE) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Prudential's (PRU) Unit Expands Travel Assistance Offerings
by Zacks Equity Research
Prudential's (PRU) arm chooses IMG to upgrade its travel assistance suite and a new insurance product.
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
5 Stocks to Soar in 2020 After Solid Gains in 2019
by Zacks Equity Research
U.S. stocks rallied to attained fresh all-time highs in 2019, as the momentum continued in 2020. Here are five stocks that are poised to grow.
Is EverQuote (EVER) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (EVER) Outperforming Other Finance Stocks This Year?
Reasons Why Investors Should Buy MGIC Investment (MTG) Stock
by Zacks Equity Research
MGIC Investment (MTG) is poised to grow on the back of lower claims payments and prudent capital deployment.
Here's Why Investors Should Hold on to Aflac (AFL) Stock
by Zacks Equity Research
Aflac (AFL) is poised for growth on the back of favorable performance in its U.S. business and a strong capital position despite softness in Japan business.
EverQuote, Inc. (EVER) Is Up 7.1% in One Week: What You Should Know
by Zacks Equity Research
Does EverQuote, Inc. (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.